It’s not easy to get depression-detecting AI through the FDA

For the past seven years, the Californiabased startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as opensource.